Gamelin Erick 4
4 · Acrivon Therapeutics, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2025-02-14$5.42/sh−469$2,542→ 16,492 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.